Online Only Articles

Alternatively spliced fibronectin extra domain A is required for hemangiogenic recovery upon bone marrow chemotherapy

Department of Molecular Medicine, University of Pavia, Italy;Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy
Department of Molecular Medicine, University of Pavia, Italy
Laboratory of Molecular Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
Department of Molecular Medicine, University of Pavia, Italy;Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy
Immunohaematology and Transfusion Service, Apheresis and Cell Therapy Unit, IRCCS San Matteo Foundation, Pavia, Italy
Laboratory of Molecular Gastroenterology, Humanitas Clinical and Research Center, Rozzano, Milan, Italy
Department of Translational Research, National Cancer Center (IRCCS CRO), Aviano, Italy;Department of Molecular and Experimental Medicine, The Scripps Research Institute, La Jolla, CA, USA
The International Centre for Genetic Engineering and Biotechnology, Trieste, Italy
Department of Molecular Medicine, University of Pavia, Italy;Laboratory of Biotechnology, IRCCS San Matteo Foundation, Pavia, Italy;Department of Biomedical Engineering, Tufts University, Medford, MA, USA
Vol. 103 No. 2 (2018): February, 2018 https://doi.org/10.3324/haematol.2017.173070